233 related articles for article (PubMed ID: 28447336)
1. Review of recent molecular landscape knowledge of gastric cancer.
Shimizu D; Kanda M; Kodera Y
Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the molecular diagnostics of gastric cancer.
Kanda M; Kodera Y
World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
[TBL] [Abstract][Full Text] [Related]
4. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer.
Sawaki K; Kanda M; Kodera Y
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):657-670. PubMed ID: 29902383
[TBL] [Abstract][Full Text] [Related]
5. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as promising biomarkers for gastric cancer.
Wang F; Sun GP; Zou YF; Hao JQ; Zhong F; Ren WJ
Cancer Biomark; 2012; 11(6):259-67. PubMed ID: 23248184
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
Yang Z; Guo X; Li G; Shi Y; Li L
Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
[TBL] [Abstract][Full Text] [Related]
8. Pathogenetic mechanisms in gastric cancer.
Shi J; Qu YP; Hou P
World J Gastroenterol; 2014 Oct; 20(38):13804-19. PubMed ID: 25320518
[TBL] [Abstract][Full Text] [Related]
9. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
Mu YP; Sun WJ; Lu CW; Su XL
Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
[TBL] [Abstract][Full Text] [Related]
11. Role of microRNAs in gastric cancer.
Ishiguro H; Kimura M; Takeyama H
World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330
[TBL] [Abstract][Full Text] [Related]
12. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
[TBL] [Abstract][Full Text] [Related]
13. Update on molecular biomarkers for diagnosis and prediction of prognosis and treatment responses in gastric cancer.
Sasahara M; Kanda M; Kodera Y
Histol Histopathol; 2021 Aug; 36(8):817-832. PubMed ID: 33719028
[TBL] [Abstract][Full Text] [Related]
14. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
[TBL] [Abstract][Full Text] [Related]
15. miR-488 acts as a tumor suppressor gene in gastric cancer.
Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S
Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864
[TBL] [Abstract][Full Text] [Related]
16. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
Beeharry MK; Liu WT; Yan M; Zhu ZG
World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
[TBL] [Abstract][Full Text] [Related]
17. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in gastric cancer early diagnosis.
Necula L; Matei L; Dragu D; Neagu AI; Mambet C; Nedeianu S; Bleotu C; Diaconu CC; Chivu-Economescu M
World J Gastroenterol; 2019 May; 25(17):2029-2044. PubMed ID: 31114131
[TBL] [Abstract][Full Text] [Related]
19. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
[TBL] [Abstract][Full Text] [Related]
20. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer.
da Silva Oliveira KC; Thomaz Araújo TM; Albuquerque CI; Barata GA; Gigek CO; Leal MF; Wisnieski F; Rodrigues Mello Junior FA; Khayat AS; de Assumpção PP; Rodriguez Burbano RM; Smith MC; Calcagno DQ
World J Gastroenterol; 2016 Sep; 22(35):7951-62. PubMed ID: 27672290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]